the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Official Title A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)
Principal Investigator Stock, Wendy
Brief Summary This screening and multi-sub-study Phase 1b/2 trial will establish a method for genomic screening followed by assigning and accruing simultaneously to a multi-study "Master Protocol (BMAL-16-001-M1)." The specific subtype of acute myeloid leukemia will determine which sub-study, within this protocol, a participant will be assigned to evaluate investigational therapies or combinations with the ultimate goal of advancing new targeted therapies for approval. The study also includes a marker negative sub-study which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Gender All
Ages 60 Years
Enrollment 500
Accepts Healthy Volunteers No
Lead Sponsor Beat AML, LLCOther
Collaborator
Study Design
Study Phase Phase 1/Phase 2
Study Type Interventional
Contact Name Eytan M Stein, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Previously Untreated Acute Myeloid Leukemia
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI